Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer - Gucalp, A; Tolaney, S; Isakoff, S J (Clin Cancer Res, 2013)
, et al; Translational Breast Cancer Research Consortium (TBCRC 011).